Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moses Egesa

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Plos Neglected Tropical Diseases|April 2, 2026
Advances in vaccine development through the controlled human infection models for hookworm and schistosomiasisMarie-Astrid Hoogerwerf, Moses Egesa, Selidgji Todagbe Agnandji, et al.
Trends in Parasitology|August 19, 2017
Rethinking Schistosomiasis Vaccine Development: Synthetic VesiclesMoses Egesa, Karl F Hoffmann, Cornelis H Hokke, et al.
Frontiers in Immunology|March 4, 2021
The Genetics of Human Schistosomiasis Infection Intensity and Liver Disease: A ReviewEstelle M Mewamba, Oscar A Nyangiri, Harry A Noyes, et al.
The Journal of General Virology|June 24, 2021
Mosquito-borne arboviruses in Uganda: history, transmission and burdenMartin N Mayanja, Frank N Mwiine, Julius J Lutwama, et al.
The Journal of General Virology|October 5, 2021
Mosquito-borne arboviruses in Uganda: history, transmission and burdenMartin N Mayanja, Frank N Mwiine, Julius J Lutwama, et al.
Global Bioethics = Problemi Di Bioetica|July 11, 2022
Ethical and practical considerations arising from community consultation on implementing controlled human infection studies using <i>Schistosoma mansoni</i> in UgandaMoses Egesa, Agnes Ssali, Edward Tumwesige, et al.
Plos One|November 22, 2017
Use of QuantiFERON®-TB Gold in-tube culture supernatants for measurement of antibody responsesSimon G Kimuda, Irene Andia-Biraro, Moses Egesa, et al.
Biology Methods & Protocols|May 17, 2023
UCP-LF and other assay methods for schistosome circulating anodic antigen between 1978 and 2022Ilemobayo Victor Fasogbon, Patrick Maduabuchi Aja, Erick Nyakundi Ondari, et al.
Plos One|November 6, 2014
Impact of co-infections and BCG immunisation on immune responses among household contacts of tuberculosis patients in a Ugandan cohortIrene A Biraro, Moses Egesa, Frederic Toulza, et al.
Frontiers in Immunology|September 13, 2021
Type 2 Diabetes Mellitus and Latent Tuberculosis Infection Moderately Influence Innate Lymphoid Cell Immune Responses in UgandaPhillip Ssekamatte, Marjorie Nakibuule, Rose Nabatanzi, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Plos Neglected Tropical Diseases|April 2, 2026
Advances in vaccine development through the controlled human infection models for hookworm and schistosomiasisMarie-Astrid Hoogerwerf, Moses Egesa, Selidgji Todagbe Agnandji, et al.
Trends in Parasitology|August 19, 2017
Rethinking Schistosomiasis Vaccine Development: Synthetic VesiclesMoses Egesa, Karl F Hoffmann, Cornelis H Hokke, et al.
Frontiers in Immunology|March 4, 2021
The Genetics of Human Schistosomiasis Infection Intensity and Liver Disease: A ReviewEstelle M Mewamba, Oscar A Nyangiri, Harry A Noyes, et al.
The Journal of General Virology|June 24, 2021
Mosquito-borne arboviruses in Uganda: history, transmission and burdenMartin N Mayanja, Frank N Mwiine, Julius J Lutwama, et al.
The Journal of General Virology|October 5, 2021
Mosquito-borne arboviruses in Uganda: history, transmission and burdenMartin N Mayanja, Frank N Mwiine, Julius J Lutwama, et al.
Global Bioethics = Problemi Di Bioetica|July 11, 2022
Ethical and practical considerations arising from community consultation on implementing controlled human infection studies using <i>Schistosoma mansoni</i> in UgandaMoses Egesa, Agnes Ssali, Edward Tumwesige, et al.
Plos One|November 22, 2017
Use of QuantiFERON®-TB Gold in-tube culture supernatants for measurement of antibody responsesSimon G Kimuda, Irene Andia-Biraro, Moses Egesa, et al.
Biology Methods & Protocols|May 17, 2023
UCP-LF and other assay methods for schistosome circulating anodic antigen between 1978 and 2022Ilemobayo Victor Fasogbon, Patrick Maduabuchi Aja, Erick Nyakundi Ondari, et al.
Plos One|November 6, 2014
Impact of co-infections and BCG immunisation on immune responses among household contacts of tuberculosis patients in a Ugandan cohortIrene A Biraro, Moses Egesa, Frederic Toulza, et al.
Frontiers in Immunology|September 13, 2021
Type 2 Diabetes Mellitus and Latent Tuberculosis Infection Moderately Influence Innate Lymphoid Cell Immune Responses in UgandaPhillip Ssekamatte, Marjorie Nakibuule, Rose Nabatanzi, et al.
Pageof 4